Investment

VR for brain training and tracking cognitive health

Virtuleap currently fundraising to build headcount and capitalise on cognitive illness detection algorithms. Ever since the US Federal Trade Commission fined Lumosity $2 million for...

Start-ups – are you solving a meaningful problem?

Forward Partners’ Luke Smith shares his views on early stage investment. With the inaugural Biohacking Congress arriving in London tomorrow, we had just enough time...

Biohacking and the future of health and Longevity

Talking investment with Octopus Ventures’ Uzma Choudry and what she's looking for in a breakthrough technology. Next week, the first Biohacking Congress will be held...

Functional age biomarker tracking goes digital

AgeMeter brings physical age measurement into the 21st century. With the recent explosion in direct-to-consumer genetic testing kits and services, the measurement of our functional...

NeuroTech Analytics releases industry-first report

New open-access analytical report profiles top technologies, sectors, trends, companies, investors, R&D hubs and influencers in the Global NeuroTech Industry “Global NeuroTech Industry Landscape Overview...

Proteomics and biological age measurement

AgeCurve closes in on first round investment as it builds its team with the support of key opinion leaders in aging research. UK start-up AgeCurve...

Alkahest Parkinson’s clinical trial gets funding boost

Alkahest announced today that they have initiated a phase 2 clinical trial with funding from the Michael J. Fox Foundation (MJFF). Today's press release reveals...

Insurer puts down £20m to research an aging rethink

A new partnership between Legal & General and Edinburgh University aims to address the societal and economic implications of an aging society. The world is...

Singapore to start human Longevity studies

Prof Brian Kennedy: "One of the reasons I came to Singapore is that the government recognises the problem of aging." In this second part of...

Revel Pharmaceuticals’ seed round for anti-aging drugs

Top Yale lab spawns new company focused on development of glucosepane-cleaving drugs. San Francisco based biotech start-up Revel Pharmaceuticals has announced itself to the...

Evolution 2.0 prize: The $10 million question

Major new prize announced to help identify how cells intentionally self-organise and communicate; George Church part of judging panel. The origin of life is often...

Longevity stocks: Stay private longer?

Going public as a Longevity stock is all about good timing and good clinical results: Some stand-out performers have experienced a volatile year. The world’s...

NeoGenomics acquires Human Longevity’s oncology tech

Acquisition of Human Longevity’s oncology division for $37m demonstrates both the opportunities and challenges for Longevity investing. On Friday, NeoGenomics announced that it had agreed...

Meet the Startup: Megilla – online storytelling

Easy to use Megilla platform is fundraising to scale-up its service to help older people share (and preserve) their life stories. Following on from last...

It’s all in the numbers; small sets of numbers

AI start-up NetraMark targets $3 million seed round while identifying that an exciting repurposing candidate has potential for indication expansion into Longevity. “I won’t tell you...

Longevity start-ups: 10 to watch in 2020

CNBC, a US television business news channel and website compiles a list of 100 of the most-promising venture-backed start-ups: Upstart100 With our Longevity focus firmly...

AgeX expects promising Longevity future

In its end of year letter to shareholders, AgeX Therapeutics sees a bright future for the Longevity market. Longevity.Technology: The days when aging was considered...

Longevity stocks: Go public with caution

SENS chief warns Longevity companies on perils of floating too soon. There is no doubt that the Longevity market is starting to take off. But...

AI innovators prefer autonomy to big pharma

AI drug discovery is hot; researchers expect it to reach US$20 billion in the next five years. Advances in AI see it is being used...

Washington’s Innovation in Longevity Summit

Conference to explore the global innovation opportunity in the Longevity market. Next week, the second Washington Innovation in Longevity Summit will be held in the...

Latest articles

Join me at my 100th birthday party in 2049!

We speak with GRG's Johnny Adams, a key contributor to the Longevity2020 online conference, about his quest for more healthy years. One of the speakers at this month’s...

Call for consensus in defining biological aging

We speak with a key contributor to the Longevity2020 online conference about biological aging. UK start-up AgeCurve is focused on the measurement of aging and...

Low-dose rapamycin to protect elderly from COVID-19

Longevity researcher proposes clinical trials for low-dose rapamycin (and other geroprotectors) to protect the elderly from COVID-19. The UK's Biogerontology Research Foundation today announced the...

Reprogram, rejuvenate, rewind: spinout

Soaking up Longevity - a Stanford University team has rejuvenated aging human cells with a novel protein "bath" and formed a spinout. Researchers at Stanford...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.